Clinicopathological significance and impact on outcomes of the gene expression levels of IGF-1, IGF-2 and IGF-1R, IGFBP-3 in patients with colorectal cancer: Overexpression of the IGFBP-3 gene is an effective predictor of outcomes in patients with colorectal cancer
Authors:
- 28 March 2017
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 13 (5) , 3958-3966
Abstract
The insulin‑like growth factors (IGF) system is involved in tumor proliferation, invasion and metastasis in cancer. The current study investigated the association of IGF‑1, IGF‑2 and IGF‑1 receptor (IGF‑1R), IGF binding proteins type 3 (IGFBP‑3) mRNA expression levels with clinicopathological characteristics and outcomes of 202 patients with untreated colorectal cancer (CRC). IGF‑1, IGF‑2, IGF‑1R and IGFBP‑3 mRNA expression levels were analyzed in surgical specimens of cancer tissues and adjacent normal mucosa cells using reverse transcription‑quantitative polymerase chain reaction. The IGF‑1R gene expression level was significantly higher in cancer tissue compared with adjacent normal mucosa. By contrast, IGF‑1 gene expression levels were reduced in cancer tissue compared with normal mucosa. IGF‑2 and IGFBP‑3 gene expression levels did not differ significantly between cancer tissue and adjacent normal mucosa. As for the association of gene expression and clinicopathological characteristics, IGFBP‑3 gene expression was significantly associated with lymph node metastasis. High IGFBP‑3 gene expression was associated with poor 5‑year overall survival compared with patients with low IGFBP‑3 expression. Furthermore, IGFBP‑3 gene expression was identified as an independent prognostic factor using multivariate analysis. Overexpression of the IGFBP‑3 gene is considered an effective independent predictor of outcomes in patients with CRC.Keywords
This publication has 35 references indexed in Scilit:
- Diabetes mellitus and cancer risk: Review of the epidemiological evidenceCancer Science, 2012
- Growth hormone, the insulin-like growth factor axis, insulin and cancer riskNature Reviews Endocrinology, 2010
- A standard curve based method for relative real time PCR data processingBMC Bioinformatics, 2005
- The role of the insulin-like growth factor system in colorectal cancer: review of current knowledgeInternational Journal of Colorectal Disease, 2005
- Insulin‐like growth factor ligands, receptors, and binding proteins in cancerThe Journal of Pathology, 2005
- Insulin-Like Growth Factor Binding Protein-3 Expression Is Associated with Growth Stimulation of T47D Human Breast Cancer Cells: The Role of Altered Epidermal Growth Factor SignalingThe Journal of Clinical Endocrinology & Metabolism, 2004
- Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysisThe Lancet, 2004
- Cellular Actions of the Insulin-Like Growth Factor Binding ProteinsEndocrine Reviews, 2002
- Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF-Binding Protein-3JNCI: Journal of the National Cancer Institute, 1999
- Expression of Insulin-Like Growth Factor-2 Can Predict the Prognosis of Human Colorectal Cancer Patients: Correlation with Tumor Progression, Proliferative Activity and SurvivalOncology, 1998